Listed

Nortech Systems Inc: Form 10-Q for the period ended Jun 30, 2013

Filed with the SEC on Aug 9, 2013 and accepted by EDGAR at Aug 9, 2013, 10:29 ET.

Share

Management's discussion and analysis

As filed, 12,904 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Overview:

We are a Wayzata, Minnesota based full-service Electronics Manufacturing Services (EMS) contract manufacturer of wire and cable assemblies, printed circuit board assemblies, higher-level assemblies and box builds for a wide range of industries. We provide value added services and technical support including design, testing, prototyping and supply chain management to customers mainly in the Aerospace and Defense, Medical, and Industrial Equipment markets. We maintain manufacturing facilities in Baxter, Bemidji, Blue Earth, Mankato, Merrifield, and Milaca, Minnesota; Augusta, Wisconsin; and Monterrey, Mexico.

Summary of Results:

For the quarter ended June 30, 2013, we reported net sales of $28.5 million compared to $28.0 million reported in the same quarter of 2012, a 1% increase year over year and a 10% increase sequentially from the first quarter of 2013.

Our gross profit percentage for the three and six months ended June 30, 2013 was 11.8% and 12.1%, respectively. The gross profit percentage for the three and six months ended June 30, 2012 was 11.0% and 10.8%, respectively. The improvement in gross margin is the result of favorable product mix and an increased investment in automation along with our continued lean initiatives.

Income from operations was approximately $373,000 and $597,000 for the three and six months ended June 30, 2013, respectively and $319,000 and $647,000 for the three and six months ended June 30, 2012, respectively.

Net income for the second quarter of 2013 was $187,219 or $0.07 per diluted common share, compared to net income of $125,925 or $0.05 per diluted common share for the same period in 2012. Net income for the six months ended June 30, 2013 was $328,308 or $0.12 per diluted common share, while net income for the same period in 2012 totaled $248,730 or $0.09 per diluted common share.

Cash used in operating activities in the first six months of 2013 was $1.4 million while cash provided by operating activities was $1.3 million in the first six months of 2012. The difference in cash used in the first six months of 2013 compared to the first six months of 2012 is mainly due to a buildup of inventory to support future production schedules and timing differences on collections of our accounts receivable.

Results of Operations:

The following table presents statements of income data as percentages of total net sales for the periods indicated:

Three Months Ended June 30 2013 2012 Six Months Ended June 30 2013 2012
Net Sales 100.0% 100.0% 100.0% 100.0%
Cost of Goods Sold 88.2 89.0 87.9 89.2
Gross Profit 11.8 11.0 12.1 10.8
Selling Expenses 4.2 4.1 4.4 4.0
General and Administrative Expenses 6.3 5.8 6.6 5.7
Income from Operations 1.3 1.1 1.1 1.1
Other Expenses, Net (0.3) (0.4) (0.4) (0.5)
Income Before Income Taxes 1.0 0.7 0.7 0.6
Income Tax Expense 0.3 0.3 0.1 0.2
Net Income 0.7% 0.4% 0.6% 0.4%

Net Sales:

We reported net sales of $28.5 million and $28.0 for the three months ended June 30, 2013 and 2012, respectively. Our Aerospace and Defense customers drove the increase as we launched a number of new programs and assemblies. Net sales for the six months ended June 30, 2013 and 2012 were $54.4 million and $56.4 million, respectively. The majority of the decrease in sales year to date is related to our Industrial customers who continue to be impacted by the slow economy.

Net sales by industry markets for the three and six month periods ended June 30, 2013 and 2012 are as follows:

Three Months Ended June 30 Six Months Ended June 30
2013 2012% 2013 2012%
(in thousands) $$ Change $$ Change
Aerospace and Defense 5,036 3,408 48 9,701 8,067 20
Medical 8,100 8,067 0 15,877 15,892 0
Industrial 15,315 16,558 (8) 28,798 32,435 (11)
Total Sales 28,451 28,033 1 54,376 56,394 (4)

Backlog:

Our 90-day order backlog as of June 30, 2013 was approximately $19.3 million, compared to approximately $20.3 million at the beginning of the quarter and $17.3 million at June 30, 2012. Our backlog consists of firm purchase orders and we expect a major portion of the current 90 day backlog to be realized as revenue during the following quarter. Orders for Medical and Defense customers remain strong heading into the 3rd quarter while our Industrial orders remain soft.

Backlog by industry market is shown below:

(in thousands)

Backlog as of the Quarter Ended June 30 2013 March 31 2013 June 30 2012
Aerospace and Defense $5,117 $5,496 $3,275
Medical 7,366 7,621 5,858
Industrial 6,768 7,230 8,161
Total Backlog $19,251 $20,347 $17,294

Our 90 day backlog varies due to order size, manufacturing delays, contract terms and conditions and timing from customer delivery schedules and releases. These variables cause inconsistencies in comparing the backlog from one period to the next.

Gross Profit:

Gross profit as a percent of net sales for the three months ended June 30, 2013 and 2012 was 11.8% and 11.0% of net sales, respectively. Gross profit percentage for the six months ended June 30, 2013 and 2012 was 12.1% and 10.8%, respectively. Our gross margin improvement is due to a favorable product mix, increased automation and manufacturing cost reduction lean workouts.

Selling Expense:

Our selling expenses were $1.2 million or 4.2% of net sales and $1.2 million or 4.1% of net sales for the three months ended June 30, 2013 and 2012, respectively. Selling expenses were $2.4 million or 4.4% of net sales and $2.2 million or 4.0% of net sales for the six months ended June

30, 2013 and 2012, respectively. We continue to invest in business development infrastructure and marketing initiatives in an effort to stimulate sales.

General and Administrative Expense:

Our general and administrative expenses were $1.8 million or 6.3% of net sales and $1.6 million or 5.8% of net sales for the three months ended June 30, 2013 and 2012, respectively. General and administrative expenses were $3.5 million or 6.6% of net sales and $3.2 million or 5.7% of net sales for the six months ended June 30, 2013 and 2012, respectively. The increase in general and administrative expenses is due to people and incentive expenses.

Income Taxes:

Our effective tax rate for the three and six months ended June 30, 2013 was 34% and 19%, respectively, compared with 38% and 35%, respectively for the three and six months ended June 30, 2012, respectively. The decreases are principally due to the federal government retroactively reinstating the research and development credit in the 1st quarter of 2013 for the 2012 tax year and extending it to 2013. The differences between federal income taxes computed at the federal statutory rate and reported income taxes for the three and six months ended June 30, 2013 and 2012 are as follows:

Three Months Ended June 30 2013 2012 Six Months Ended June 30 2013 2012
Statutory federal tax provision $97,000 $63,000 $140,000 $125,000
State income taxes 13,000 12,000 23,000 16,000
Income tax credits (17,000) (3,000) (103,000) (6,000)
Change in uncertain tax positions 8,000 (2,000) 22,000 8,000
Other (3,000) 6,000 (5,000) (8,000)
Income tax expense $98,000 $76,000 $77,000 $135,000

Liquidity and Capital Resources:

We have satisfied our liquidity needs over the past several years with cash flows generated from operations and an operating line of credit through WFB. We also have real estate and equipment term loans. Both the line of credit and real estate term notes are subject to fluctuations in the LIBOR rates. The line of credit, real estate term notes, and equipment loans with WFB contain certain covenants which, among other things, require us to adhere to regular reporting requirements, abide by annual shareholder dividend limitations, maintain certain financial performance, and limit the amount of annual capital expenditures. The availability under our line is subject to borrowing base requirements, and advances are at the discretion of the lender. The line of credit is secured by substantially all of our assets.

On June 30, 2013, we had outstanding advances of $8.7 million under the line of credit and unused availability of $3.9 million supported by our borrowing base. We believe our financing arrangements and cash flows to be provided by operations will be sufficient to satisfy our future working capital needs. Our working capital was $14.6 million and $12.6 million as of June 30, 2013 and December 31, 2012, respectively. The increase in working capital relates primarily to increased accounts receivable and inventory levels related to the revenue and planned production increases.

Net cash used in operating activities for the six months ended June 30, 2013 was $1.4 million. Increased inventories, accounts receivable and decreases in accounts payable were partially offset by an increase in accrued payroll and commissions and noncash depreciation expense.

Net cash used in investing activities of $0.6 million for the six months ended June 30, 2013 is comprised primarily of property and equipment purchases to support the business.

Net cash provided by financing activities for the six months ended June 30, 2013 was $2.1 million, mainly due to loan proceeds of $1.7 million related to the purchase of the Mankato facility and increased borrowings on the line of credit of $0.8 million to fund operations, offset by payments on long-term debt of $0.4 million.

Critical Accounting Policies and Estimates

Our significant accounting policies and estimates are summarized in Management’s Discussion and Analysis of Financial Condition and Results of Operations in our Annual Report on Form 10-K for the year ended December 31, 2012. There have been no significant changes in these critical accounting policies since December 31, 2012. Some of our accounting policies require us to exercise significant judgment in selecting the appropriate assumptions for calculating financial estimates. Such judgments are subject to an inherent degree of uncertainty. These judgments are based on our historical experience, known trends in our industry, terms of existing contracts and other information from outside sources, as appropriate. Actual results could differ from these estimates.

Forward-Looking Statements:

Those statements in the foregoing report that are not historical facts are forward-looking statements made pursuant to the safe-harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements generally will be accompanied by words such as “anticipate,” “believe,” “estimate,” “expect,” “forecast,” “intend,” “possible,” “potential,” “predict,” “project,” or other similar words that convey the uncertainty of future events or outcomes. Although we believe these forward-looking statements are reasonable, they are based upon a number of assumptions concerning future conditions, any or all of which may ultimately prove to be inaccurate. Forward-looking statements involve a number of risks and uncertainties. Important factors that could cause actual results to differ materially from the forward-looking statements include, without limitation:

  • Volatility in the marketplace which may affect market supply and demand for our products;
  • Increased competition;
  • Changes in the reliability and efficiency of operating facilities or those of third parties;
  • Risks related to availability of labor;
  • Increase in certain raw material costs such as copper;
  • Commodity and energy cost instability;
  • General economic, financial and business conditions that could affect our financial condition and results of operations; and
  • Availability of raw material components.

The factors identified above are believed to be important factors (but not necessarily all of the important factors) that could cause actual results to differ materially from those expressed in any forward-looking statement made by us. Unpredictable or unknown factors not discussed herein could also have material adverse effects on forward-looking statements. All forward-looking statements included in this Form 10-Q are expressly qualified in their entirety by the forgoing cautionary statements. We undertake no obligations to update publicly any forward-looking statement (or its associated cautionary language) whether as a result of new information or future events.

Please refer to forward-looking statements and risks as previously disclosed in our report on Form 10-K for the fiscal year ended December 31, 2012.

Controls and procedures

As filed, 1,479 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Evaluation of Disclosure Controls and Procedures:

In accordance with Rule 13a-15(b) of the Securities Exchange Act of 1934 (the “Exchange Act”), as of the end of the period covered by this Quarterly Report on Form 10-Q, our management evaluated, with the participation of our Chief Executive Officer and President, Chief Operating and Financial Officer, the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) and Rule 15d-15(e) under the Exchange Act). Based upon their evaluation of these disclosure controls and procedures, the Chief Executive Officer and the President, Chief Operating and Financial Officer have concluded that the disclosure controls and procedures were effective as of the date of such evaluation in ensuring that information required to be disclosed in our Exchange Act reports is (1) recorded, processed, summarized and reported in a timely manner, and (2) accumulated and communicated to management, including our Chief Executive Officer and President, Chief Operating and Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.

Changes in Internal Control Over Financial Reporting:

There was no change in our internal control over financial reporting that occurred during the period covered by this Quarterly Report on Form 10-Q that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2013-06-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2013-04-01 to 2013-06-30$28.5mus-gaap:SalesRevenueNet
Revenue6 months2013-01-01 to 2013-06-30$54.4mus-gaap:SalesRevenueNet
Cost of revenue3 months2013-04-01 to 2013-06-30$25.1mus-gaap:CostOfGoodsAndServicesSold
Cost of revenue6 months2013-01-01 to 2013-06-30$47.8mus-gaap:CostOfGoodsAndServicesSold
Gross profit3 months2013-04-01 to 2013-06-30$3.4mus-gaap:GrossProfit
Gross profit6 months2013-01-01 to 2013-06-30$6.6mus-gaap:GrossProfit
Operating income3 months2013-04-01 to 2013-06-30$373.1kus-gaap:OperatingIncomeLoss
Operating income6 months2013-01-01 to 2013-06-30$596.7kus-gaap:OperatingIncomeLoss
Interest expense3 months2013-04-01 to 2013-06-30$105.0kus-gaap:InterestExpense
Interest expense6 months2013-01-01 to 2013-06-30$198.5kus-gaap:InterestExpense
Income tax3 months2013-04-01 to 2013-06-30$98.0kus-gaap:IncomeTaxExpenseBenefit
Income tax6 months2013-01-01 to 2013-06-30$77.0kus-gaap:IncomeTaxExpenseBenefit
Net income3 months2013-04-01 to 2013-06-30$187.2kus-gaap:NetIncomeLoss
Net income6 months2013-01-01 to 2013-06-30$328.3kus-gaap:NetIncomeLoss
Operating cash flow6 months2013-01-01 to 2013-06-30−$1.4mus-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
Capital expenditure6 months2013-01-01 to 2013-06-30$665.2kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2013-06-30$0us-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2013-06-30$35.8mus-gaap:AssetsCurrent
Total assetsAt period end2013-06-30$47.2mus-gaap:Assets
Current liabilitiesAt period end2013-06-30$21.2mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2013-06-30$25.7mus-gaap:Liabilities
Long-term debtAt period end2013-06-30$4.1mus-gaap:LongTermDebtNoncurrent
Current portion of debtAt period end2013-06-30$563.8kus-gaap:LongTermDebtCurrent
Shareholders' equityAt period end2013-06-30$21.5mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001104659-13-062094. Last ingested by Listed: Nov 12, 2026, 19:20 ET. Listed shows no prices and gives no investment advice.